P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study

• S.A Hurvitz,
• A.F Schott,
• C. Ma,
• E.P Hamilton,
• R. Nanda,
• G. Zahrah,
• N. Hunter,
• A.R Tan,
• M.L Telli,
• J.A. Mesias,
• R. Jeselsohn,
• P. Munster,
• H. Lu,
• R. Gedrich,
• C. Mather,
• J. Parameswaran,
• H.S Han,
• S. Wirth

Affiliations

S.A Hurvitz

A.F Schott

C. Ma

E.P Hamilton

R. Nanda

G. Zahrah

N. Hunter

A.R Tan

M.L Telli

J.A. Mesias

R. Jeselsohn

P. Munster

H. Lu

R. Gedrich

C. Mather

J. Parameswaran

H.S Han

S. Wirth